DrugPatentWatch Database Preview
Sagent Pharms Inc Company Profile
Email this page to a colleague
See Plans and PricingWhat is the competitive landscape for SAGENT PHARMS INC, and what generic and branded alternatives to SAGENT PHARMS INC drugs are available?
SAGENT PHARMS INC has forty-six approved drugs.
Summary for Sagent Pharms Inc
| US Patents: | 0 |
| Tradenames: | 40 |
| Ingredients: | 39 |
| NDAs: | 46 |
Drugs and US Patents for Sagent Pharms Inc
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sagent Pharms Inc | GEMCITABINE HYDROCHLORIDE | gemcitabine hydrochloride | INJECTABLE;INJECTION | 209077-003 | Jul 20, 2018 | AP | RX | No | No | Start Trial | Start Trial | ||||
| Sagent Pharms Inc | IBANDRONATE SODIUM | ibandronate sodium | INJECTABLE;INTRAVENOUS | 202235-001 | Sep 2, 2014 | AP | RX | No | No | Start Trial | Start Trial | ||||
| Sagent Pharms Inc | OCTREOTIDE ACETATE (PRESERVATIVE FREE) | octreotide acetate | INJECTABLE;INJECTION | 090834-002 | Nov 12, 2013 | AP | RX | No | No | Start Trial | Start Trial | ||||
| Sagent Pharms Inc | AMPICILLIN SODIUM | ampicillin sodium | INJECTABLE;INJECTION | 090583-003 | Nov 27, 2015 | AP | RX | No | No | Start Trial | Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
